Navigation Links
Genoptix and HistoRx Announce Licensing Agreement for AQUA(R) Technology
Date:2/19/2010

CARLSBAD, Calif. and NEW HAVEN, Conn., Feb. 19 /PRNewswire-FirstCall/ -- Genoptix, Inc. (Nasdaq: GXDX), a specialized laboratory service provider, and HistoRx, Inc. (privately held), a diagnostics company, today announced a multi-year licensing agreement for AQUA® technology and several diagnostic assays based on it.  Genoptix has obtained exclusive commercial laboratory rights in the United States to develop and perform three solid tumor assays using HistoRx's proprietary technology for analysis of fluorescent immunohistochemistry (fIHC), enabling quantitative assessment of specific biomarkers for patients with certain solid tumors.


'/>"/>
SOURCE Genoptix, Inc.; HistoRx, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Genoptix Announces Participation at Lazard Capital Management 6th Annual Healthcare Conference
2. Genoptix Announces Participation at the 2009 Southern California Investor Conference
3. Genoptix Announces Participation at the Twentieth Annual Piper Jaffray Healthcare Conference
4. Genoptix Ranked Ninth Fastest-Growing Company in North America on Deloittes 2008 Technology Fast 500
5. Genoptix Announces Participation at the BIOCOM Investor Conference 2008
6. Genoptix Announces Participation at the UBS Global Life Sciences Conference
7. Genoptix Reports Strong Financial Results For Third Quarter 2007
8. HistoRx Names Dick Carroll, Ph.D. as VP of Clinical Research
9. HistoRx Names Bill Sullivan Senior Vice President, Diagnostic Operations
10. HistoRx Announces Expanded Access of AQUA(R) Technology to 900+ Researchers at Dana-Farber/Harvard Cancer Center
11. HistoRx and Lilly Extend, Expand AQUA(R) Analysis Partnership
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... 17, 2013 Oven Industries Inc. announces ... 5R6-900 temperature controller has many user-friendly benefits. Contained all ... the wall as a self-contained temperature control ... detail makes the device unique, as well as highly ... also be used universally, which allows the user to ...
(Date:5/17/2013)... UK (PRWEB) May 17, 2013 The ... Photonics21 at the association’s recent annual meeting ... including EC Vice-President Neelie Kroes, who called the action ... sectors, and a stimulant to European innovation.” , The ... structure of the new Photonics PPP at its 29 ...
(Date:5/17/2013)... -- Yongye International, Inc. (NASDAQ: YONG ) ("Yongye" ... of crop nutrient products in the People,s ... May 16, 2013, the special committee (the "Special Committee") ... was provided a letter (the "Letter") issued by Abax ... ("Abax") to Full Alliance International Limited ("Full Alliance"). The ...
(Date:5/17/2013)... The paradigm of ‘one drug, one target’ has ... predict the adverse and therapeutic effects of a drug. ... Biology at the Genomics Laboratory, Covance, will discuss the ... when used as part of the QC process. Additionally, ... to identify key clinical targets even in complex data ...
Breaking Biology Technology:New Temperature Control Products Announced by Oven Industries Inc. 2SPIE Joins in Praise for ‘Huge Step Forward’ for Innovation R&D Enabled by Photonics21 Actions 2SPIE Joins in Praise for ‘Huge Step Forward’ for Innovation R&D Enabled by Photonics21 Actions 3Yongye International Provides Update on Status of Proposed Go Private Offer 2Yongye International Provides Update on Status of Proposed Go Private Offer 3Yongye International Provides Update on Status of Proposed Go Private Offer 4
... BEIJING, May 1 Sinovac Biotech Ltd. (NYSE Amex: ... in China, today announced that it has filed its Annual ... Commission for the year ended December 31, 2008 on May ... now available on the Company,s website under the investor relations ...
... of $79.7 Million, Increase of 29% over First Quarter 2008- ... per Diluted Share, Increases of 14% and 20% over First ... Therapeutics Corporation (Nasdaq: UTHR ) today announced its ... Total revenues for the first quarter of 2009 were ...
... Earnings Conference Call to be Held on May 15, ... / 8:00 pm (Beijing/Shanghai/Hong Kong)SHANGHAI, May 1 /PRNewswire-Asia/ -- ... a leading pharmaceutical, biotechnology and medical device R&D outsourcing ... today announced that it will release financial results for ...
Cached Biology Technology:Sinovac Biotech Ltd. Files Annual Report on Form 20-F 2United Therapeutics Reports First Quarter 2009 Financial Results 2United Therapeutics Reports First Quarter 2009 Financial Results 3United Therapeutics Reports First Quarter 2009 Financial Results 4United Therapeutics Reports First Quarter 2009 Financial Results 5United Therapeutics Reports First Quarter 2009 Financial Results 6United Therapeutics Reports First Quarter 2009 Financial Results 7WuXi PharmaTech Schedules First-Quarter 2009 Earnings Release 2
(Date:5/18/2013)... FL (May 18, 2013) An increasing number ... require interventions to resolve, according to research presented ... one study targeting obesity, researchers at the Cleveland ... a unique pattern of exhaled breath compared to ... volatile organic compound levels that can be correlated ...
(Date:5/17/2013)... Rutgers, The State University of New Jersey, and City ... formulation called Visikol TM that effectively clears organisms ... in place of chloral hydrate, which is one of ... is tightly regulated by the Drug Enforcement Administration (DEA) ... solutions, or clearing agents, are vital for viewing organisms ...
(Date:5/17/2013)... 17, 2013, Shenzhen, China---- Why Tibetan antelope can ... Plateau? In a collaborative research published in ... and other institutes provide evidence that some genetic ... to harsh highland environments. The data in this ... genetic mechanisms and the biology of other ruminant ...
Breaking Biology News(10 mins):New research identifies risks, interventions for children's GI health 2New research identifies risks, interventions for children's GI health 3New formula invented for microscope viewing, substitutes for federally controlled drug 2New formula invented for microscope viewing, substitutes for federally controlled drug 3The genome sequence of Tibetan antelope sheds new light on high-altitude adaptation 2
... a compelling case for FUZEON (enfuvirtide, formerly known as ... give patients facing resistance their best chance of achieving ... people living with HIV. , "Undetectable viral load should ... patients. FUZEON combined with the latest drugs now makes ...
... St. Louis has applied software that he has developed ... 150 genes that were missed by previous genome analysis ... have developed predictions for the existence of a whopping ... professor of computer science and engineering, used his unique ...
... Circulating stem cells play a minor role in repairing lung ... and female chromosomal differences to analyze the repair process in ... journal Transplantation, lead author Dani Zander, M.D., of The University ... University of Florida College of Medicine found that less than ...
Cached Biology News:Newest HIV drugs should be used with FUZEON(R) 2Newest HIV drugs should be used with FUZEON(R) 3Program finds lost genes in nematode genome 2Program finds lost genes in nematode genome 3Candida albicans Genome Fully Annotated 2Candida albicans Genome Fully Annotated 3
... g of lyophilized peptide derived from the ... 380-402; GLTPSAWEASSLRSSRHSGLSHF. This peptide was ... Cayman's EP1 receptor polyclonal antibody (Catalog No. ... with this antibody to block protein-antibody complex ...
... 75 x ... recommended for immunohistochemistry of paraffin-embedded sections, ... at one end, markings ... normal procedures, precleaned, ...
Complete cell culture media with cytokines...
HAS1 (C-14)...
Biology Products: